Are We There Yet? A Digital Maturity Model for Enabling Process Monitoring and Artificial Intelligence

Digital transformation promises to revolutionize biopharmaceutical manufacturing, yet most organizations leverage only a fraction of their process data — and the challenges are paradoxically increasing with digitization and globalization. Digitization does not automatically deliver analytics-ready data. New AI capabilities, from multivariate methods through foundation models and agentic systems, demand data infrastructure that most sites have never been asked to provide. This webinar introduces BioMetre, a practical maturity framework serving as a GPS for process monitoring readiness, developed and deployed across a global biologics manufacturing network. The model scores data readiness along two axes: what process data exists across six categories, and how well it flows across six delivery dimensions — freshness, frictionlessness, accessibility, authenticity, structure, and availability. Assessments across 25+ products revealed scores ranging from 30–80%, with organizations excelling at collecting critical data but struggling to make it analytically accessible. Drawing on nearly four decades applying AI to biologics manufacturing, Jack Pri…